University of Chicago Medical Center /ID# 279460

Chicago, Illinois 60637

1 studies enrolling now · 1 studies all time

What they study most

Metastatic Pancreatic Ductal Adenocarcinoma, PDAC

Studies at this site

• A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma — Recruiting now